CliffBio
small molecule

BACLOFEN

BACLOFEN

Loss of exclusivity—loss of exclusivity
CompanyMaia →See this company's full patent-cliff portfolio

Drug detail

Brand nameBACLOFEN
Active ingredientBACLOFEN
Strength0.5MG/ML
Dosage formINJECTABLE
RouteINTRATHECAL
ModalitySmall molecule
FDA approvalSeptember 2019
Marketing statusRX

More from Maia

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

BACLOFEN patent cliff — loss of exclusivity — | CliffBio